IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.710
EU - Europa 12.319
AS - Asia 11.766
SA - Sud America 1.955
AF - Africa 314
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 21
Totale 52.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.326
CN - Cina 4.229
PL - Polonia 3.958
SG - Singapore 3.723
UA - Ucraina 2.111
BR - Brasile 1.608
DE - Germania 1.495
IT - Italia 1.303
HK - Hong Kong 1.256
VN - Vietnam 809
FI - Finlandia 792
GB - Regno Unito 649
FR - Francia 554
RU - Federazione Russa 415
IN - India 404
TR - Turchia 403
IE - Irlanda 373
BD - Bangladesh 273
CA - Canada 188
SE - Svezia 118
AR - Argentina 112
ZA - Sudafrica 111
MX - Messico 107
CZ - Repubblica Ceca 102
NL - Olanda 101
ES - Italia 100
JP - Giappone 97
ID - Indonesia 96
IQ - Iraq 77
AU - Australia 68
EC - Ecuador 62
PK - Pakistan 52
MA - Marocco 47
AT - Austria 43
CO - Colombia 43
IR - Iran 43
BE - Belgio 41
VE - Venezuela 40
SA - Arabia Saudita 37
CL - Cile 32
KE - Kenya 30
NG - Nigeria 26
UZ - Uzbekistan 26
JM - Giamaica 24
CH - Svizzera 23
LT - Lituania 22
PE - Perù 22
AZ - Azerbaigian 20
MU - Mauritius 20
EU - Europa 19
IL - Israele 19
JO - Giordania 19
MY - Malesia 18
AE - Emirati Arabi Uniti 17
PH - Filippine 17
PY - Paraguay 17
EG - Egitto 16
KR - Corea 16
TN - Tunisia 16
TH - Thailandia 15
DZ - Algeria 14
KZ - Kazakistan 14
PA - Panama 13
RO - Romania 13
BG - Bulgaria 12
NO - Norvegia 11
HU - Ungheria 10
NP - Nepal 10
TW - Taiwan 10
ET - Etiopia 9
KG - Kirghizistan 9
UY - Uruguay 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
GE - Georgia 8
GR - Grecia 8
LK - Sri Lanka 8
LV - Lettonia 8
TT - Trinidad e Tobago 8
CU - Cuba 7
DK - Danimarca 7
LB - Libano 7
OM - Oman 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
CR - Costa Rica 6
HR - Croazia 6
NZ - Nuova Zelanda 6
AL - Albania 5
HN - Honduras 5
SV - El Salvador 5
BH - Bahrain 4
BY - Bielorussia 4
EE - Estonia 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
CI - Costa d'Avorio 3
CY - Cipro 3
Totale 52.100
Salva come PNG Salva come JPEG
Città #
Warsaw 3.948
Fairfield 3.027
Ashburn 2.329
Woodbridge 2.187
Singapore 1.972
Jacksonville 1.582
Houston 1.518
Hong Kong 1.243
Ann Arbor 1.180
Cambridge 1.173
San Jose 1.134
Seattle 1.103
Wilmington 1.062
Beijing 910
Chandler 798
The Dalles 732
Princeton 669
Nanjing 581
New York 523
Los Angeles 446
Helsinki 438
Brescia 389
Dublin 369
Dallas 342
Dearborn 337
Istanbul 305
Lauterbourg 303
Ho Chi Minh City 224
Munich 223
Dong Ket 181
Nanchang 180
Council Bluffs 178
San Francisco 170
Buffalo 169
São Paulo 166
Moscow 160
Milan 154
Des Moines 151
Shenyang 151
Hebei 144
Jinan 144
Changsha 139
Santa Clara 139
San Diego 137
Shanghai 136
Hanoi 126
Chicago 124
Orem 112
Tianjin 106
Lancaster 105
Jiaxing 101
London 100
Redondo Beach 97
Tokyo 88
Boardman 79
Phoenix 76
Kunming 73
Brooklyn 72
Turku 69
Hangzhou 66
Jakarta 66
Brno 64
Chennai 63
San Mateo 61
Guangzhou 60
Johannesburg 57
Rome 56
Madrid 55
Verona 54
Boston 53
Porto Alegre 51
Montreal 49
Toronto 49
Haikou 48
Rio de Janeiro 46
Amsterdam 45
Zhengzhou 45
Ningbo 44
Atlanta 43
Augusta 43
Stockholm 43
Denver 42
Lanzhou 42
Nuremberg 42
Manchester 40
Belo Horizonte 36
Brussels 35
Charlotte 35
Kocaeli 35
Mexico City 34
Poplar 34
Leawood 33
Washington 33
Frankfurt am Main 31
Curitiba 29
Fuzhou 29
Dhaka 28
Haiphong 28
Mumbai 28
Paris 28
Totale 36.677
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 385
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 377
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 356
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 354
The nanostructured secretome 351
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 343
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 323
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 315
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 305
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 304
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 302
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 301
Claudin3 is localized outside the tight junctions in human carcinomas 293
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 292
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 288
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 287
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 285
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 284
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 281
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 281
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 279
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 278
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 278
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 277
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 274
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 272
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 271
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 271
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 270
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 267
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 255
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 255
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 251
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 248
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 247
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 244
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 238
Zebrafish disease models in hematology: Highlights on biological and translational impact 236
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 227
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 225
Long pentraxin-3 follows and modulates bladder cancer progression 221
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 216
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 216
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 214
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 213
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 212
Anti-angiogenic activity of the purine analog 6-thioguanine. 212
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 211
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 209
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 207
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 207
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 206
The zebrafish/tumor xenograft angiogenesis assay. 206
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 206
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 206
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 205
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 202
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 202
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 201
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 201
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 197
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 196
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 196
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 194
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 194
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 192
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 191
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 191
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 190
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 189
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 189
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 188
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 188
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 187
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 187
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 186
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 186
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 186
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 184
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 183
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 182
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 181
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 181
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 177
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 177
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 177
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 177
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 177
Beta-Galactosylceramidase deficiency: neurovascular implications 176
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 176
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 174
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 174
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 174
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 172
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 169
Circulating microRNAs and Their Role in Multiple Myeloma 169
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 168
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 167
Totale 23.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 228.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 0 0 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/202613.368 1.327 1.675 1.078 1.838 1.441 883 2.044 444 792 1.113 538 195
Totale 52.910